Royal London Asset Management LTD Medtronic PLC Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Medtronic PLC stock. As of the latest transaction made, Royal London Asset Management LTD holds 561,578 shares of MDT stock, worth $47.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

561,578

Previous 552,671 1.61%

Holding current value

$47.2 Million

Previous $43.5 Million 16.23%

% of portfolio

0.13%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $684,413 - $810,804	8,907 Added 1.61%	561,578 $50.6 Million
Q2 2024 Aug 07, 2024	SELL	$78.71 - $87.02 $125,070 - $138,274	-1,589 Reduced 0.29%	552,671 $43.5 Million
Q1 2024 May 14, 2024	BUY	$82.84 - $88.09 $934,269 - $993,479	11,278 Added 2.08%	554,260 $48.3 Million
Q4 2023 Feb 13, 2024	BUY	$69.43 - $83.43 $1.02 Million - $1.23 Million	14,743 Added 2.79%	542,982 $44.7 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $869,258 - $1 Million	11,113 Added 2.15%	528,239 $41.4 Million
Q2 2023 Aug 11, 2023	BUY	$79.47 - $91.38 $2.29 Million - $2.64 Million	28,875 Added 5.91%	517,126 $45.6 Million
Q1 2023 May 15, 2023	BUY	$76.72 - $87.58 $575,783 - $657,287	7,505 Added 1.56%	488,251 $39.4 Million
Q4 2022 Feb 09, 2023	BUY	$76.18 - $87.74 $1.09 Million - $1.25 Million	14,274 Added 3.06%	480,746 $37.4 Million
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $2.23 Million - $2.63 Million	-27,608 Reduced 5.59%	466,472 $37.7 Million
Q2 2022 Aug 12, 2022	BUY	$87.4 - $113.09 $269,978 - $349,335	3,089 Added 0.63%	494,080 $44.4 Million
Q1 2022 May 13, 2022	BUY	$100.58 - $112.38 $1.5 Million - $1.68 Million	14,949 Added 3.14%	490,991 $54.5 Million
Q4 2021 Oct 18, 2022	SELL	$99.53 - $127.75 $262,261 - $336,621	-2,635 Reduced 0.55%	476,042 $49.2 Million
Q4 2021 Aug 16, 2022	BUY	$99.53 - $127.75 $47.4 Million - $60.8 Million	476,042 New	476,042 $49.2 Million
Q4 2021 Jan 18, 2022	SELL	$99.53 - $127.75 $47.6 Million - $61.2 Million	-478,677 Closed	0 $0
Q3 2021 Oct 18, 2022	SELL	$122.75 - $135.17 $1.54 Million - $1.7 Million	-12,545 Reduced 2.55%	478,677 $60 Million
Q3 2021 Aug 16, 2022	BUY	$122.75 - $135.17 $58.8 Million - $64.7 Million	478,677 New	478,677 $60 Million
Q3 2021 Nov 02, 2021	SELL	$122.75 - $135.17 $60.3 Million - $66.4 Million	-491,222 Closed	0 $0
Q2 2021 Oct 18, 2022	SELL	$118.19 - $131.5 $337,787 - $375,827	-2,858 Reduced 0.58%	491,222 $61 Million
Q2 2021 Aug 16, 2022	BUY	$118.19 - $131.5 $58.1 Million - $64.6 Million	491,222 New	491,222 $61 Million
Q2 2021 Jul 14, 2021	SELL	$118.19 - $131.5 $58.1 Million - $64.6 Million	-491,222 Closed	0 $0
Q1 2021 Oct 17, 2022	SELL	$111.18 - $119.74 $317,752 - $342,216	-2,858 Reduced 0.58%	491,222 $58.1 Million
Q1 2021 Aug 16, 2022	BUY	$111.18 - $119.74 $54.6 Million - $58.8 Million	491,222 New	491,222 $58.1 Million
Q4 2019 Feb 05, 2020	SELL	$104.49 - $114.54 $71.5 Million - $78.4 Million	-684,219 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$98.02 - $111.18 $67.1 Million - $76.1 Million	684,219 New	684,219 $74.3 Million
Q2 2019 Jul 31, 2019	SELL	$84.15 - $99.38 $58.6 Million - $69.2 Million	-696,603 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$82.45 - $93.79 $1.52 Million - $1.73 Million	18,407 Added 2.71%	696,603 $0
Q4 2018 Jan 29, 2019	BUY	$85.8 - $99.49 $58.2 Million - $67.5 Million	678,196 New	678,196 $60.5 Million
Q3 2018 Nov 08, 2018	SELL	$85.91 - $99.17 $49.4 Million - $57.1 Million	-575,553 Closed	0 $0
Q2 2018 Sep 19, 2018	BUY	$77.48 - $87.83 $44.6 Million - $50.6 Million	575,553 New	575,553 $49.3 Million

Others Institutions Holding MDT

# of Institutions

2,283

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $112B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Medtronic PLC Transaction History